Why is Halozyme Therapeutics stock sliding today?

More in Finance

• Data centers need power, so why did this Dow stock fall 26%?

  An unnamed Dow stock has experienced a sharp 26% decline, raising questions amid the ongoing demand for data center power infrastructure. Further details explaining the specific causes behind the drop were not provided in the initial report.

  1 min read
• Penny stock under ₹10 hits 5% upper circuit on Dhanteras 2026 date; finds no seller for third straight session

  Vellora Impact Ltd experienced intense buyer demand after reporting a dramatic operational turnaround following its pivot away from chemical manufacturing toward IT services and agricultural trading. The company's recent earnings report revealed massive revenue expansion driven predominantly by farm commodity transactions. This strategic transformation has rapidly altered the financial profile of the BSE-listed microcap firm.

  4 min read
• Binance $6.3 billion heist to prompt closer scrutiny by insurers

  Underwriters are intensifying their evaluations of cryptocurrency companies' cyber defenses and direct industry exposures during policy negotiations and annual renewals. The unprecedented attack highlights severe capacity limits in digital asset coverage, where single policies cannot absorb multi-billion-dollar losses. Furthermore, potential state-sponsored attribution introduces legal complications that threaten to trigger standard policy exclusions.

  3 min read